neobookRx
GuidelinesOther guideline

An Approach to a Breast Mass and Other Common Breast Complaints

Doctor, I have a lump in my breast! An approach to a breast mass and other common breast complaints

Introduction
Clinical Findings on Breast Examination
Differential Diagnosis of a Breast Lump
Differential Diagnosis of Breast Thickening
Differential Diagnosis of Skin Dimpling
Differential Diagnosis of Nipple Discharge
Differential Diagnosis of Breast Pain
Breast Diagnostics
Imaging Techniques
Biopsy Techniques
Guidelines to Special Investigation
Management of Fibroadenomas
Gynecomastia
Breast Cancer


Context: Outpatients

Introduction

The central clinical question is whether the lump is breast cancer or not. Since breast cancer is the commonest cancer to affect women in most countries, this is a frequent scenario.

History taking is aimed at identifying symptoms suggestive of a benign breast lump and evaluating the patient's risks for breast cancer. Take a gynaecological history as well.

The most powerful risk factors for the development of breast cancer are age (postmenopausal), gender (women! obvious!), previous breast carcinoma or predisposing breast pathology (DCIS/LCIS/atypical ductal hyperplasia), a family history of breast or ovarian carcinoma, and previous radiotherapy to the chest wall.

Undress the patients, and examine systematically both breasts, the axillae and the supraclavicular fossa. Use the palm of your hand (not your fingertips) and evaluate for lumps, tenderness, adenopathy; look for signs of skin dimpling, ulcerations, skin oedema, or fixity.

More than half of all patients who present with a breast lump have a normal examination (i.e. they don't have a lump!)- the breasts are markedly variable in consistency and nodularity, and some patients and less experienced clinicians can over-interpret normal breast consistency.

The patient's age and clinical context is critically important- the older the patient, the more likely the diagnosis of breast cancer. A number of benign conditions occurring elsewhere (such as lipomas, sebaceous cysts) can also cause breast lumps.

Clinical Findings on Breast Examination

Clinical Findings on Breast Examination
Normal
Clinical findings vary enormously depending on patients’ age, pregnancy status, adiposity. The upper outer quadrant and the infra-mammary fold are areas of increased breast density, which is normal. Young women have much more dense, “nodular” breast tissue.
Thickening
Area of increased breast density, which is different from the surrounding tissue and is asymmetrical, but is not as clearly defined as a breast lump. If you were to excise it, you would struggle to define its exact extent and may remove a large area.
Lump
A localised swelling, protuberance, bulge or bump in the breast that feels different from the breast tissue around it or the breast tissue in the same area of the other breast. If you are to biopsy it, you would be able to exactly define where the lump ends and the normal parenchyma starts.
Skin Dimpling
Best seen in a sitting position with the arms elevated- notice a small dimple in the skin overlying a breast lump- it is strongly associated with breast carcinoma- very few benign breast conditions cause dimpling.
Nipple Discharge
Spontaneous, persistent, blood-stained single duct discharge merits investigation.
Bilateral, clear, non-spontaneous discharge is common and clinically
irrelevant.

Differential Diagnosis of a Breast Lump

Common
Clues
Breast carcinoma
Presents as a painless, firm lump.
More overt signs (adenopathy, skin oedema, ulcerations)- occur in advanced cases.

Breast cyst

Perimenopausal patients, smooth lump, tender to pressure
Fibroadenoma
Adolescent and young patients, well defined, smooth very mobile mass
Breast abscess
Commonest in late pregnancy or breastfeeding/ usually obvious clinical diagnosis based on findings of erythema, tenderness, fluctuation, purulent discharge
Periductal mastitis
95% are smokers, causing chronic retro-areolar inflammatory masses and recurrent abscess and fistulae
Fat necrosis
Follows a traumatic event (direct injury i.e. seatbelt injury after MVA or assault)
Can be very similar clinically to a breast carcinoma- hard, craggy, irregular

Uncommon and Weird
Clues
TB
Commonest in HIV+ patients, either as a chronic abscess / or with axillary adenopathy/sinus
Galactocele
In breastfeeding
Phyllodes tumours
Feels like a large fibroadenoma in an older patient, but can become enormous
Metastases to the breast
Melanoma or lymphoma can present with suspicious breast masses
Don’t want to miss
Clues
Breast carcinoma
Be absolutely sure that a “benign lump” is properly evaluated, and histology reports are representative

Differential Diagnosis of a Breast Lump in Different Clinical Contexts

Context
Diagnosis
Comments
Adolescent
Fibroadenoma
Breast cancer is exceedingly rare in this context.
Young women have dense, nodular breasts which can be difficult to evaluate, this can lead to over-referral to breast clinics
Pregnancy
Lactational abscess
Galactocele
Breast carcinoma
Pregnant women have dense, nodular breasts which can be difficult to evaluate. Breast cancer can be easily missed in this context.
Fibroadenomas can occur in this context, and typically hypertrophy during pregnancy
Middle age
Breast carcinoma
Cyst
Fat necrosis
Periductal mastitis
In patients older than 40, breast cancer starts to be a probable diagnosis
Fibroadenoma is very uncommon
Look at benign diagnoses with “suspicion” & evaluate fully
Elderly
Breast carcinoma
Almost all breast lumps in this age group are malignant
Male
Gynaecomastia
Breast carcinoma
1% of breast cancer occurs in men
Gynaecomastia can be caused by drugs (spironolactone/ steroids/ ARV’s) or liver failure
HIV +
Breast carcinoma
TB
Lymphoma
Consider TB and lymphoma is patients with marked adenopathy
The most likely cause remains breast carcinoma

Differential Diagnosis of Breast Thickening

Common
Clues
Normal
Bilateral symmetrical UOQ thickening
Fibrocystic breast change
Areas of fibro-cystic change can feel different to surrounding tissue. This is common in perimenopausal patients
Carcinoma
Carcinoma may be less easy to feel in breast parenchyma that is thick, and nodular
Lobular carcinoma typically presents with ill-defined thickening, rather than a well-demarcated mass
Periductal mastitis
95% are smokers, causing chronic retro-areolar inflammatory masses and recurrent abscess and fistulae
Don’t want to miss
Clues
Breast carcinoma
-

Differential Diagnosis of Skin Dimpling

Common
Clues
Carcinoma
Most skin dimpling is caused by carcinomas, even small
impalpable lesions
Surgical scars
Prior surgery can leave “gaps” of breast parenchyma that
distort skin appearance
Don’t want to miss
Clues
Breast carcinoma
Look for occult primary lesions if nil palpable

Differential Diagnosis of Nipple Discharge

Common
Clues
Intraductal papilloma
Single duct, spontaneous blood-stained or clear serous discharge
DCIS / carcinoma
Single duct, spontaneous blood-stained or clear serous discharge
Carcinoma may have an associated irregular mass or thickening
Periductal mastitis
Smoker, recurrent infections, usually a yellow purulent discharge from the nipple or peri-areolar fistula
Ductal ectasia
>1 duct, fluid can be dark green/ brown
Don’t want to miss
Clues
Breast carcinoma
Look for occult primary lesions if nil palpable.

Differential Diagnosis of Breast Pain

Common
Clues
Physiological mastalgia
>95% of all cases of breast pain are physiological and do not correlate to any underlying breast pathology. This is commonest in adolescent and around menopause but may occur at any age.
Less common
Focal, localized, persistent breast tenderness may reflect a local breast condition
Breast abscess
Obvious clinical diagnosis in almost all cases
Fat necrosis
On occasion, this can be tender
Breast cyst
A tender breast lump, in perimenopausal woman
Fibroadenoma
A small proportion can be tender to pressure, but most are asymptomatic
Referred Pain
Costo-chondral tenderness typically just lateral to the sternum, on focal pressure = Tietze’s syndrome.
Herpes zoster giving referred pain from dermatomal innervation.
Thrombosed vein within the breast parenchyma. On palpation, it feels like a tender “chord” of tissue- Mondor’s disease

Breast carcinoma
A locally advanced, ulcerated carcinoma can cause local pain.
An impalpable or early breast carcinoma is typically NOT painful. If a patient has mastalgia AND breast cancer it is more commonly a coincidence, rather than cause and effect

Don't want to miss
Clues
Breast carcinoma

Examine patients thoroughly, and reassure about the benign nature of mastalgia
Any clinical signs must be evaluated on their merits

Breast Diagnostics

Triple assessment is the gold standard for the evaluation of a breast mass: ie (1) clinical evaluation must be supported by appropriate (2) imaging and (3) tissue biopsy.

Always consider if all 3 aspects of the assessment are concordant (in agreement) or discordant (don't make sense!)- The bottom line is: if the investigations are CONCORDANT (ie if clinical, biopsy and imaging features are malignant- the final diagnosis will be malignant, and conversely if clinically and all the investigations are benign then the diagnosis will be benign!) or DISCORDANT (i.e. the biopsy reports a malignant lesion, but the imaging looks benign, or vice versa) - discordant reports mandate either repeat investigations or surgery to clarify the diagnosis.

Imaging Techniques

Mammogram
US
MRI
Strengths
  • Cheap
  • Widely available
  • Suitable for most patients
  • Cheap
  • Widely available
  • Can guide biopsies
  • Useful in patients with dense breast tissue
  • Excellent quality imaging
  • No radiation
  • Suitable in all breast density
Weaknesses
  • Radiation exposure
  • Not ideal in patients with high breast density
  • Subjective / operator dependent
  • Can't see microcalcifications well
  • Very expensive
  • Oversensitive
  • Not widely available
  • Use very selectively
False +ve
<5%
<5%
10%
False -ve
5-10%
5-10%
<5%

Be aware that a normal mammogram does not exclude cancer with 100% confidence - approximately 10% of malignancies are missed on imaging (10% false negative rate) - never disregard a suspicious clinical sign, even if radiology is reassuring - a biopsy is a critical part of the "triple assessment".

Characteristic Features of Breast Cancer on Imaging

Mammography
Ultrasound
  • Dense soft tissue mass / opacity
  • Spiculation
  • Architectural distortion
  • Pleomorphic microcalcifications
  • Adenopathy
  • Oedema of the skin
  • Hypoechoic solid
  • Presence of microcalcifications
  • Taller than it is wide
  • Suspicious axillary lymph nodes suggesting. metastatic disease
  • Intra-lesional nodular blood flow
  • Irregular edge

BI-RADS Classification: all reports should classify the findings according to the BI-RADS system

Assessment
Management
Cancer Probability
1 - negative
Follow up only if clinically indicated
0%
2 - benign
Follow up only if clinically indicated
0%
3 - probably benign
Review in 6/12 or routine screening (if indicated)
<2%
4 - suspicious
a- low suspicion
b- intermediate 
suspicion
c- high suspicion
Tissue diagnosis

2-10%
10-50%
50-95%

5 - highly suggestive of malignancy
Tissue diagnosis
>95%
6 - known biopsy - proven malignancy

-
n/a

Biopsy Techniques

FNA cytology
Strengths
Weakness
False +ve
False -ve
Cheapest
Widely available
Easy to learn
Can be done in consultation rooms
Indadequate sampling
Cytology report only
Cannot offer definitive treatment on the result
Cannot distinguish infiltrating cancer from DCIS
<1%
5-10% (mostly related to sampling errors)
Needle core biopsy
Strengths
Weakness
False +ve
False -ve
Gold standard
Not expensive
Can be done in a consultation room
Obtain a sample for histology examination
More complex to learn
Needles 10x >expensive than FNA
Lab costs greater
<0.05%
<5% if done correctly
Excision biopsy
Strengths
Weakness
False +ve
False -ve
Large volume of tissue obtained = representative
Expensve
Requires procedure/theatre room
Hospital costs
Leaves a scar
<0.01%
<0.1%
Punch biopsy
Strengths
Weakness
False +ve
False -ve
Suitable for skin lesions only
Cheap
Histology examination
Limited clinical use to skin abnormalities only (i.e. Paget's disease of the nipple
-
-

Biopsy results should be reported as follows (IACC standards):

Cytology
C1
Insufficient material
C2
Benign
C3
Atypical probably benign
C4
Suspicious, probably in situ or invasive carcinoma
C5
Malignant
Histology
B1
Insufficient material
B2
Benign
B3
Atypical probably benign
B4
Suspicious, probably in situ or invasive carcinoma
B5
Malignant

The most definitive test to confirm or exclude cancer is always HISTOLOGY - if the lesion has been correctly biopsied (either by core needle or excision biopsy) this gives unequivocal information about the diagnosis; if the patient has a malignancy, it gives the treating team details about histological and genetic profiling subtype, hormone receptors, tumour grade, vascular invasion - all of which help plan treatment. None of these details is reliably obtained from cytology aspiration (or from radiological investigations!!).

Guidelines to Special Investigation

Click on the above images to enlarge

Management of Fibroadenomas

Clinical features of a typical FA

  • <3cm
  • well defined, smooth
  • mobile
  • firm
  • may be mildly tender or multiple

Management of a typical fibroadenoma under 3cm

< 20 yr old
Investigations
Management
Follow up if not excised
Indications for surgery
Nil
Reassure
None
Not recommended
20-25 yr old
Investigations
Management
Follow up if not excised
Indications for surgery
Ultrasound
Reassure
None if the US and clinical exam are consistent with FA
Patient request
25-30 yr old
Investigations
Management
Follow up if not excised
Indications for surgery
Histology + Ultrasound
Offer excision
Annual x 2 yrs
Most patients
> 30 yr old
Investigations
Management
Follow up if not excised
Indications for surgery
Histology
US + Mammo
Recommend excision
6 monthly x 2 yrs
All patients

Indications for Surgery in any age group

  • Giant fibroadenoma (> 5cm in size)
  • Atypical clinical presentation: fixed, irregular, skin changes, lymphadenopathy, rapid growth
  • Suspicious biopsy or ultrasound result

Gynecomastia

Gynecomastia is a benign enlargement of the male breast due to proliferation of the glandular component. It is caused by a relative imbalance between oestrogen and androgen levels and can be caused by a wide range of conditions. Gynaecomastia peaks during puberty and in 50 to 80-year-olds. Clinically, gynecomastia is a firm, rubbery, mobile, disc-like mound of tissue arising concentrically from beneath the nipple and areola region. Unilateral and bilateral gynecomastia are both common and benign. The overwhelming majority of cases are idiopathic and of no clinical significance.

Organic causes of gynecomastia

Prescription drugs: e.g. Spironolactone, anti-androgens, anabolic steroids, HAART in particular efavirenz, diazepam, tricyclic antidepressants, cimetidine, digoxin, calcium channel blockers

Recreational substances:  e.g. Alchohol, amphetamines, marijuana, heroin, methadone

Organ dysfunction: e.g. Liver failure, renal failure, thyrotoxicosis

Endicrinopathy: e.g. Testicular carcinoma, Cushing's syndrome

Causes of unilateral gynecomastia or retroareolar mass:

  • All causes of bilateral gynecomastia
  • Breast carcinoma
  • Benign breast lump

Click on the above image to enlarge

Doctor, I am worried I will get breast cancer - I want to be tested!

Take a thorough breast history and examine fully. Any clinical findings need to be investigated contextually.

Formal analysis of risk can be done using online tools- (IBIS Risk Evaluation is the one we use at our GSH breast clinic). This will issue a report with the likelihood of cancer within the next 5, 10 years and overall lifetime risk. (http://ibis.ikonopedia.com or download file to install on desktop at http://www.ems-trials.org/riskevaluator/)

Most patients grossly over-estimate their risk of developing cancer, and need thoughtful compassionate reassurance.

The following patients should be referred for genetic counselling and testing:

  • IBIS lifetime risk estimated >30%
  • BRCA mutation risk estimated >10%

Drugs mentioned

NeoHealth® ID 18381 · updated 9/15/2021